However, Hims & Hers has put the brakes on sales of its compounded version amid potential legal action from top health officials who said the drug violates U.S
Phase 2 data showing 24% body weight loss is in humans, not mice but Phase 3 scale and long-term safety data are still pending
At this point, there is no completed clinical evidence showing that ultra-low GLP-1 dosing prevents Alzheimers disease
Patients should be aware that key safety considerations include: Hypersensitivity to the active substance or excipients Pregnancy or breastfeeding Risk of pancreatitis and gallbladder disease Potential for dehydration with severe gastrointestinal side effects A thorough medical assessment, including review of current medications and comorbidities, is essential before initiating treatment
Ipamorelin Side Effects Ipamorelins safety and efficacy have yet to be evaluated in long-term human clinical trials so little is known about its potential side effects
As previously mentioned, early studies using direct measurements in muscle after 14 days on 4 to 6 g of carnitine per day failed to show increases in the muscle carnitine concentration (4, 5)